US Clinical Decision Support System (CDSS) Growth Opportunities

US Clinical Decision Support System (CDSS) Growth Opportunities

Sparking Future Growth Potential for Health Data, AI, and SDoH to Increase Accuracy and Efficiency among Providers and Payers and Improve the Patient Journey

RELEASE DATE
08-Mar-2022
REGION
North America
Research Code: K711-01-00-00-00
SKU: HC03517-NA-MT_26361
$4,950.00
In stock
SKU
HC03517-NA-MT_26361
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform.

This report reviews the growth opportunities that are driving the US CDSS market. It provides the current market segmentation that includes a mix of established content-based solutions and technical companies that are attracted to the CDSS space. The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.

Research Scope

For the purpose of this study, Frost & Sullivan has mapped and forecasted clinical decision support systems based on a mix of evidence (content), analytics, workflow, and point-of-care (POC) solutions. The study attempts to focus specifically on solutions that have a visible presence within the CDSS space. A number of start-ups are building new solutions that have earned minimal revenue, but some of these companies will be listed. Also, the study includes examples of companies that are outside of the CDSS market but offer adjacent data inputs and solutions that add value to a CDSS. The revenue estimates focus only on revenue attributed to CDSS. In some cases, such as analytics, EHR, or medical device companies, CDSS revenue represents a small part of a larger revenue stream. The study period is 2021–2026 with forecasts covering 2022–2026.


Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the US CDSS Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Executive Summary

Scope of Analysis

Segmentation

Key Growth Metrics

Key Competitors

Growth Drivers

Growth Driver Analysis

Growth Driver Analysis (continued)

Growth Restraints

Growth Restraint Analysis

Growth Restraint Analysis (continued)

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Application

Revenue Forecast Analysis

Competitive Environment

CDSS Market—Mergers & Acquisitions

CDSS Market—Mergers & Acquisitions (continued)

Key Growth Metrics

Revenue Forecast

Revenue Forecast Analysis

Key Growth Metrics

Revenue Forecast

Forecast Analysis

Key Growth Metrics

Revenue Forecast

Forecast Analysis

Key Growth Metrics

Revenue Forecast

Forecast Analysis

Case Study—Change Healthcare, a Payer/Provider Ecosystem

Case Study—Wolters Kluwer, Building an End-to-End Solution in a Patient-centric Model

Growth Opportunity 1—Develop Disease-specific CDS Algorithms to Help Avoid Need for ICU Admission or Re-admission for Patients with Chronic Conditions

Growth Opportunity 1—Develop Disease-specific CDS Algorithms to Help Avoid Need for ICU Admission or Re-admission for Patients with Chronic Conditions (continued)

Growth Opportunity 2—Incorporate Updated, Peer-reviewed, and Actionable Evidence to Support Long-term Rehabilitation Post Surgery

Growth Opportunity 2—Incorporate Updated, Peer-reviewed, and Actionable Evidence to Support Long-term Rehabilitation Post Surgery (continued)

Growth Opportunity 3—Establish Omni-channel CDS through a Platform-as-a-Service Capability to Reduce the Burden of Antibiotics

Growth Opportunity 3—Establish Omni-channel CDS through a Platform-as-a-Service Capability to Reduce the Burden of Antibiotics (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

Related Research
Clinical decision support (CDS) is a broad concept with many definitions that are used variably, depending on the perspective and role of the expert. It includes a mix of evidence (content), analytics, workflow, devices, and software-based solutions that must include electronic health records (EHRs) and be maintained by an IT platform. This report reviews the growth opportunities that are driving the US CDSS market. It provides the current market segmentation that includes a mix of established content-based solutions and technical companies that are attracted to the CDSS space. The 4 segments covered are decision evidence and protocols, decision workflow, decision analytics, and decision delivery.--BEGIN PROMO--

Research Scope

For the purpose of this study, Frost & Sullivan has mapped and forecasted clinical decision support systems based on a mix of evidence (content), analytics, workflow, and point-of-care (POC) solutions. The study attempts to focus specifically on solutions that have a visible presence within the CDSS space. A number of start-ups are building new solutions that have earned minimal revenue, but some of these companies will be listed. Also, the study includes examples of companies that are outside of the CDSS market but offer adjacent data inputs and solutions that add value to a CDSS. The revenue estimates focus only on revenue attributed to CDSS. In some cases, such as analytics, EHR, or medical device companies, CDSS revenue represents a small part of a larger revenue stream. The study period is 2021–2026 with forecasts covering 2022–2026.

More Information
No Index No
Podcast No
Author Delfina Huergo
Industries Healthcare
WIP Number K711-01-00-00-00
Is Prebook No
GPS Codes 9564-B1,9600-B1,9612-B1